Deutsche Bank Ag\ Neurocrine Biosciences Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 437,831 shares of NBIX stock, worth $55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

437,831

Previous 433,107 1.09%

Holding current value

$55 Million

Previous $59.6 Million 15.46%

% of portfolio

0.02%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $541,275 - $723,480	4,724 Added 1.09%	437,831 $50.4 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $9.59 Million - $10.5 Million	73,251 Added 20.36%	433,107 $59.6 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $2.97 Million - $3.27 Million	22,780 Added 6.76%	359,856 $49.6 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $6.34 Million - $7.94 Million	59,776 Added 21.56%	337,076 $44.4 Million
Q3 2023 Nov 09, 2023	SELL	$94.02 - $117.1 $7.54 Million - $9.39 Million	-80,189 Reduced 22.43%	277,300 $31.2 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $1.55 Million - $1.81 Million	17,284 Added 5.08%	357,489 $33.7 Million
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $32.5 Million - $42.5 Million	-345,315 Reduced 50.37%	340,205 $34.4 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $28.7 Million - $34.2 Million	269,065 Added 64.61%	685,520 $81.9 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $2.85 Million - $3.34 Million	-30,979 Reduced 6.92%	416,455 $44.2 Million
Q2 2022 Aug 11, 2022	BUY	$75.79 - $100.07 $2.57 Million - $3.4 Million	33,960 Added 8.21%	447,434 $43.6 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $34,123 - $44,655	471 Added 0.11%	413,474 $38.8 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $1.33 Million - $1.77 Million	-16,655 Reduced 3.88%	413,003 $35.2 Million
Q3 2021 Nov 04, 2021	BUY	$86.18 - $99.03 $211,571 - $243,118	2,455 Added 0.57%	429,658 $41.2 Million
Q2 2021 Aug 11, 2021	SELL	$89.43 - $102.27 $5.49 Million - $6.28 Million	-61,403 Reduced 12.57%	427,203 $41.6 Million
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $4.34 Million - $5.91 Million	49,521 Added 11.28%	488,606 $47.5 Million
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $6.08 Million - $7.57 Million	-69,910 Reduced 13.73%	439,085 $42.1 Million
Q3 2020 Nov 12, 2020	SELL	$96.16 - $135.15 $37.8 Million - $53.1 Million	-393,169 Reduced 43.58%	508,995 $48.9 Million
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $2.55 Million - $3.9 Million	29,917 Added 3.43%	902,164 $110 Million
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $8.21 Million - $12.4 Million	-109,243 Reduced 11.13%	872,247 $75.5 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $7.53 Million - $10.3 Million	86,768 Added 9.7%	981,490 $105 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $789,500 - $956,028	-9,419 Reduced 1.04%	894,722 $80.6 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $8.7 Million - $11 Million	-120,494 Reduced 11.76%	904,141 $76.3 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $13.2 Million - $17.4 Million	189,878 Added 22.75%	1,024,635 $90.3 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $6.29 Million - $11.5 Million	-92,095 Reduced 9.94%	834,757 $59.6 Million
Q3 2018 Dec 21, 2021	BUY	$98.88 - $125.85 $13.4 Million - $17.1 Million	136,002 Added 17.2%	926,852 $114 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $664,572 - $845,837	6,721 Added 0.86%	790,850 $97.2 Million
Q2 2018 Apr 21, 2020	BUY	$75.3 - $105.99 $6.94 Million - $9.77 Million	92,181 Added 13.32%	784,129 $77 Million
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $23 Million - $32.3 Million	-304,995 Reduced 30.59%	691,948 $68 Million
Q1 2018 Oct 18, 2019	BUY	$75.88 - $92.43 $8.33 Million - $10.2 Million	109,830 Added 12.38%	996,943 $82.7 Million
Q1 2018 May 15, 2018	SELL	$75.88 - $92.43 $6.15 Million - $7.5 Million	-81,092 Reduced 8.38%	887,113 $73.6 Million
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $28.2 Million - $37.3 Million	-480,975 Reduced 33.19%	968,205 $75.1 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $69.5 Million - $88.8 Million	1,449,180	1,449,180 $88.8 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account